Patients Debate Anon Iv Safety After New Clinical Trial Results

Patients Debate Anon Iv Safety After New Clinical Trial Results

What is clinical research?
MSN: Comprehensive study settles debate over diet safety for patients with cancer

MSN: Shares of this gene therapy maker are up 30%. The safety debate is far from over. Shares of this gene therapy maker are up 30%. The safety debate is far from over.

Training a new breed of clinical triallist

Training a new breed of clinical triallist

The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in patients with previously treated non-small cell lung cancer (NSCLC) whose ... Bimekizumab demonstrated a consistent safety profile across patients with PsA or axSpA in an integrated safety analysis, with the drug showing long-term tolerability. Phase 1 data demonstrates durable responses and rPFS coupled with a manageable safety profile rPFS of 7.9-8.9 months in heavily pre-treated mCRPC patients Preliminary results are encouraging with deep ...
Zanubrutinib shows sustained superior PFS in CLL patients without del(17p), regardless of IGHV mutation status. The safety profile of zanubrutinib remains consistent, with low atrial fibrillation ... For decades, patients undergoing blood cancer treatment have been told to avoid certain foods to reduce infection risk, guidance that some physicians hoped could safely be relaxed. Now, a University ... The Connecticut Mirror: Connecticut cannabis is safe. Here’s why that matters for patients. We want patients and families to hear this first: Connecticut’s medical cannabis program is safe, tightly regulated, and designed to protect people who rely on it. Every product in the legal market is ... Stay on top of the latest developments related to patient education. Browse the AMA’s patient education resources, full of information and tools that physicians can share with their patients, including educational handouts for patients and other patient education materials.
For this installment, three AMA members took time to discuss what doctors wish patients knew about the potentially harmful effects of social media. They are: Nusheen Ameenuddin, MD, MPH, a pediatrician in Rochester, Minnesota, and chair of the American Academy of Pediatrics Council on Communications and Media. The discussion was moderated by William B. Jordan, MD, MPH, who is senior director of equity policy and transformation at the AMA Center for Health Equity. Panelists examined the quality of care older-adult physicians provide, how age-related biases affect older-adult physicians, and how ageism affects patients’ care experience. The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines and how to take charge of their health through preventive care. Getting patients to make healthy lifestyle choices ranks high on every physician’s professional wish list. But realistically accomplishing this goal requires care teams to zero in on what really patients really want. The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines. Three physicians took time to discuss what doctors wish patients knew about vitamins and nutritional supplements. They are: Pieter Cohen, MD, an internist in Somerville ... Patients with Meniere’s disease “will have episodes of vertigo, usually lasting half an hour to a couple of hours that can be very intense and incapacitating and unpredictable, but they almost always have a symptom of hearing loss or ringing in their ear either immediately before or during the onset of vertigo,” he said. Public Health Prevention & Wellness What doctors wish patients knew about iron deficiency One in three women under 50 is iron deficient, affecting about 10 million people in the U.S. Two physicians discuss iron deficiency and how to address it. The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines and how to take charge of their health through preventive care. For this installment, two AMA members shared what doctors wish patients knew about sodium consumption. They are: Most patients are diagnosed at a far less treatable, later stage of the disease. And with about 20% of lung cancer deaths preventable, evidence-based screening recommendations for high-risk patients offer the best hope to catch the disease early and provide the best chance for effective treatment. A medical oncologist shares more. Patient perspectives around data privacy The American Medical Association partnered with Savvy Cooperative, a patient-owned source of health care insights, to survey 1,000 patients across the U.S. on their perspectives toward the privacy of their medical information. We found that by understanding the patient perspective on data privacy, industry and government can better act to help patients ...

New EU clinical trial regulation - Clinical Trial Services, UK | PHARMExcel

New EU clinical trial regulation - Clinical Trial Services, UK | PHARMExcel

Read also: Why the recent revitalization of prospect ave matters for businesses